Jade Biosciences, Inc. JBIO
NASDAQ · United States · Health Technology
$14.13+0.36 (+2.61%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.76 | -0.64 | -19.4% | $0 | — | +1.8%$21.96→$22.35 |
| Q1 2026 | 2026-05-07 | -0.57 | -0.52 | -9.6% | — | — | +2.7%$25.13→$25.81 |
| Q4 2025 | 2026-03-06 | -0.11 | -0.45 | +75.6% | — | — | +4.0%$13.88→$14.43 |
| Q3 2025 | 2025-11-13 | -0.48 | -0.57 | +15.8% | — | — | +7.0%$10.00→$10.70 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.